Psoriasis Excellence Forum

Lawrence Green, MD, associate clinical professor of dermatology at George Washington University School of Medicine in Washington, DC, and on the National Psoriasis Foundation Medical Board, reviews current biologic therapies available for psoriasis and shares…

By Melissa Weiss, Associate Editor, The Dermatologist Craig A. Elmets, MD, professor of dermatology at the University of Alabama in Birmingham. As more evidence supports the association between psoriasis and comorbid conditions, including cardiovascular…

This article originally appeared in the April issue of The Dermatologist.  By Melissa Weiss, Associate Editor Within the last decade, advances in the understanding of psoriasis and new therapeutic options have transformed the treatment landscape for this…

The National Psoriasis Foundation (NPF) and American Academy of Dermatology (AAD) recently released two joint guidelines for the management and treatment of psoriasis on February 13, 2019. These two guidelines are the first two of series of six guidelines to…

Steven Feldman, MD, PhD, professor of dermatology at the Wake Forest School of Medicine, discusses costs associated with psoriasis drugs and focuses specifically on the impact these costs have on insurers.     Podcast Transcript: Hi, I…

Core domains patients and health care providers say all clinical trials of psoriasis therapies should measure are skin manifestations, symptoms of psoriasis and psoriatic arthritis, investigator global assessment, patient global assessment, health-related…

Complementary and alternative medicine (CAM) therapies with the most robust evidence of effectiveness in the treatment of plaque psoriasis are indigo naturalis, curcumin, dietary modification, fish oil, meditation, and acupuncture, according to a systematic…